Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for improvement of ascites in cirrhotic patients
TCTR20241016007Phase 2Unknown
- Sponsor
- N/A
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dapagliflozin in Cirrhosis and ascites (2 arms), sponsored by N/A. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
Cirrhosisascites
Beyond the preview
Go deeper on TCTR20241016007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241016007.